Global and Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size, Status and Forecast 2021-2027

Global and Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size, Status and Forecast 2021-2027

  • QYResearch
  • January 2022
  • Healthcare
  • 99 pages

Report Description

Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Scope and Market Size
Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pertuzumab
Trastuzumab

Segment by Application
Combination Therapy
Mono Therapy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
BOC Sciences
LGM Pharma
Biotechnica Pharma Global
KinBio
Merck

Have query on this report?

Make an Enquiry
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pertuzumab
List of Tables
Table 1. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pertuzumab
Table 3. Key Players of Trastuzumab
Table 4. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Success Stories

Our Clients